Thank you to our contributors

1991 ◽  
Vol 29 (26) ◽  
pp. 104.1-104

Articles in the Bulletin have been unsigned since it began. This is because they aim to present a consensus view which incorporates contributions from many people, including specialists, general practitioners and members of the pharmaceutical industry, as well as the Bulletin’s Advisory Council. We are very grateful to them all, but although we have often been asked who they are, we cannot name the many hundreds who have helped us in any one year. However, we can at least name those not listed in our tailpiece who have taken a major share in the production of articles published in the last year, and do so now.

1987 ◽  
Vol 25 (26) ◽  
pp. 104-104

Articles in the Bulletin have been unsigned since it began. This is because they aim to present a consensus view which incorporates contributions from many people, including specialists, general practitioners and members of the pharmaceutical industry, as well as the Bulletin’s Advisory Council. We are very grateful to them all, but although we have often been asked who they are, we cannot name the many hundreds who have helped us in any one year. However, we can at least name those not listed in our tailpiece who have taken a major share in the production of articles published in the last three years, and do so now. We also warmly thank Airlie Ogilvy, our production editor who retired recently after keeping the Bulletin going for 24 years.


1984 ◽  
Vol 22 (26) ◽  
pp. 104.2-104

Articles in the Bulletin have been unsigned since it began. This is because they aim to present a consensus view which incorporates contributions from many people, including specialists, general practitioners and members of the pharmaceutical industry, as well as the Bulletin’s Advisory Council. We are very grateful to them all, but although we have often been asked who they are we cannot name the many hundreds who have helped us in any one year. However we can at least name those not listed in our tailpiece who have taken a major share in the production of articles published in 1983 and 1984, and do so now.


1990 ◽  
Vol 28 (26) ◽  
pp. 104-104

Articles in the Bulletin have been unsigned since it began. This is because they aim to present a consensus view which incorporates contributions from many people, including specialists, general practitioners and members of the pharmaceutical industry, as well as the Bulletin’s Advisory Council. We are very grateful to them all, but although we have often been asked who they are, we cannot name the many hundreds who have helped us in any one year. However, we can at least name those not listed in our tailpiece who have taken a major share in the production of articles published in the last year, and do so now.


1989 ◽  
Vol 27 (26) ◽  
pp. 104.1-104

Articles in the Bulletin have been unsigned since it began. This is because they aim to present a consensus view which incorporates contributions from many people, including specialists, general practitioners and members of the pharmaceutical industry, as well as the Bulletin’s Advisory Council. We are very grateful to them all, but although we have often been asked who they are, we cannot name the many hundreds who have helped us in any one year. However, we can at least name those not listed in our tailpiece who have taken a major share in the production of articles published in the last two years, and do so now.


1992 ◽  
Vol 30 (26) ◽  
pp. 104-104

Articles in the Bulletin have been unsigned since it began. This is because they aim to present a consensus view that incorporates contributions from many people, including specialists, general practitioners and members of the pharmaceutical industry, as well as the Bulletin’s Editorial Board and Advisory Council. We are very grateful to all contributors, but only have space to acknowledge those who have taken a major share in the production of articles published in the last year. We would like to thank by name.


1993 ◽  
Vol 31 (26) ◽  
pp. 104-104

Articles in the Bulletin have been unsigned since it began. This is because they aim to present a consensus view that incorporates contributions from many people, including specialists, general practitioners and members of the pharmaceutical industry, as well as the Bulletin’s Editorial Board and Advisory Council. We are very grateful to all contributors, but only have space to acknowledge those who have taken a major share in the production of articles published in the last year. We would like to thank by name.


Author(s):  
Hernan Tesler-Mabe

As recently as one year ago, the European Union was seemingly on a direct path toward its avowed goal of "ever closer union." In numerous publications, EU authorities asserted that they had the confidence of European peoples desirous only of further integration. In the wake of the failed referenda for a European Constitution, however, enthusiasts of European Union can no longer be certain that their enterprise will succeed. The European Union, once strong and united, seems now an entity teetering on the edge of collapse. The reasons for such a dramatic shift are, of course, wide-ranging. Yet I would suggest that a great part of the general European disillusionment with European Union has come about as a result of the actions of the Europeanists themselves. Over the last decades, European officials have exhibited a frightfully high incidence of revisionism in their literature. This practice, I argue, has caused many Europeans to question the integrity of the project of European Union. For my presentation, I intend to undertake a close study of a selection of documents published by the European Communities. In this endeavour, I will compare and contrast the messages imparted in different editions of these works and consider the semiotic significance of the textual and non-textual language appearing therein. In this manner, I hope to achieve two aims. First, I mean to add a corrective element to a literature that, guided by a teleological interpretation of integration, endows integration with”logic" to be found only in hindsight. Second, I intend to examine the many meanings that the EU has had over its history and assess how closely policy has adhered to the ideological goals of prominent Europeanists. In sum, I hope to shed light on the fundamental disconnect between advocates of Europe and the "man on the street" and help establish a dialogue which may contribute to resolving the current impasse within the European Union. Full text available: https://doi.org/10.22215/rera.v2i4.178


Author(s):  
Christopher Hanlon

Emerson’s Memory Loss is about an archive of texts documenting Emerson’s intellectual state during the final phase of his life, as he underwent dementia. It is also about the way these texts provoke a rereading of the more familiar canon of Emerson’s thinking. Emerson’s memory loss, Hanlon argues, contributed to the shaping of a line of thought in America that emphasizes the social over the solipsistic, the affective over the distant, the many over the one. Emerson regarded his output during the time when his patterns of cognition transformed profoundly as a regathering of focus on the nature of memory and of thinking itself. His late texts theorize Emerson’s experience of senescence even as they disrupt his prior valorizations of the independent mind teeming with self-sufficient conviction. But still, these late writings have succumbed to a process of critical forgetting—either ignored by scholars or denied inclusion in Emerson’s oeuvre. Attending to a manuscript archive that reveals the extent to which Emerson collaborated with others—especially his daughter, Ellen Tucker Emerson—to articulate what he considered his most important work even as his ability to do so independently waned, Hanlon measures the resonance of these late texts across the stretch of Emerson’s thinking, including his writing about Margaret Fuller and his meditations on streams of thought that verge unto those of his godson, William James. Such ventures bring us toward a self defined less by its anxiety of overinfluence than by its communality, its very connectedness with myriad others.


Itinerario ◽  
2009 ◽  
Vol 33 (2) ◽  
pp. 17-27 ◽  
Author(s):  
Már Jónsson

On 2 January 1625, the English ambassador Robert Anstruther met with King Christian IV of Norway and Denmark and requested his participation in a union of Protestant states against Emperor Ferdinand II and the Catholic League in Germany. Within three days, King Christian proposed to contribute five thousand soldiers for one year, as part of an army of almost thirty thousand men. In early June, despite opposition from the Danish Council of State, reluctant to put a huge amount of money into foreign affairs, Christian decided to join what he called “the war for the defence of Lower Saxony”. He then headed an army of mercenaries southwards through Lower Saxony, secured all crossings over the river Weser and prepared to confront the Catholic forces. On 29 November, it was decided that Denmark would be in charge of military operations in Northern Germany, whereas England and the United Provinces would provide a monthly subsidy. The political and military prospects for Denmark were excellent, to say the least. It had the fourth strongest navy in Europe (after Spain and the two new allies), and only a few years before the Danish warships had been described by a French observer as “merveilles de l'océan”. A small standing army of two regiments had recently been established and Denmark was the fourth European state to do so after France, Spain and the neighbouring Sweden.


1989 ◽  
Vol 4 (4) ◽  
pp. 241-244
Author(s):  
P. Lemoine

SummaryIt is difficult to undertake field studies with non marketed psychotropic drugs because of two apparently contradictory conditions : on the one hand, the methodology has to be rigorously controlled, and on the other hand, such studies have to be carried out in their future environment by general practitioners (GPs). Bearing in mind the lack of training and experience regarding this kind of approach, the author adopted a discussion group method according to the techniques developed by M. Balint. The study group comprised five GPs, a clinical pharmacology expert and a doctor from the pharmaceutical laboratory which had developed the test drug. These persons met on a monthly basis over a one year period. In the present paper, the author indicates the benefits of such a methodology, based on six years’ experience and several trials, with special emphasis placed on the pedagogical aspects.


Sign in / Sign up

Export Citation Format

Share Document